Moderna (MRNA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
6 May, 2026Opening remarks and agenda
Chairman welcomed attendees, introduced board members and executives, and outlined the meeting agenda.
Formal business included four proposals: election of directors, advisory vote on executive compensation, advisory vote on frequency of compensation votes, and ratification of the accounting firm.
Board and executive committee updates
Board members and executive committee were introduced, with some attending virtually.
Inspector of Election and meeting secretary roles were formally established.
Corporate governance
Shareholder list and meeting materials were made available in accordance with legal requirements.
Quorum was confirmed, allowing official business to proceed.
Voting procedures were explained, including proxy and virtual ballot options.
Latest events from Moderna
- Growth, diversification, and pipeline innovation drive a positive financial outlook through 2028.MRNA
Goldman Sachs 47th Annual Global Healthcare Conference 20269 Jun 2026 - Intismeran plus pembrolizumab halves recurrence risk and sustains immune benefit in melanoma.MRNA
Study update2 Jun 2026 - AI-driven innovation and a diversified pipeline position the company for renewed growth.MRNA
Bernstein 42nd Annual Strategic Decisions Conference28 May 2026 - 2026 growth driven by ex-U.S. partnerships, new vaccines, and strong clinical data.MRNA
RBC Capital Markets Global Healthcare Conference 202619 May 2026 - Q1 2026 revenue jumped 260%, but a $950M litigation charge led to a $1.3B net loss.MRNA
Q1 202615 May 2026 - Up to 10% revenue growth in 2026 and EU expansion in 2027 drive breakeven by 2028.MRNA
Bank of America Global Healthcare Conference 202612 May 2026 - Up to 10% revenue growth in 2026 driven by late-stage pipeline, cost discipline, and expansion.MRNA
44th Annual J.P. Morgan Healthcare Conference12 Apr 2026 - Proxy covers director elections, pay, auditor ratification, and robust cost savings in 2025.MRNA
Proxy Filing16 Mar 2026 - Key votes include director elections, executive pay, and auditor ratification for 2026.MRNA
Proxy Filing16 Mar 2026